Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Chemoradiation of rectal cancer.

Arrazubi V, Suárez J, Novas P, Pérez-Hoyos MT, Vera R, Martínez Del Prado P.

Minerva Chir. 2013 Feb;68(1):11-26. Review.

PMID:
23584263
2.

Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.

Arredondo J, Baixauli J, Beorlegui C, Arbea L, Rodríguez J, Sola JJ, Chopitea A, Hernández-Lizoáin JL.

Dis Colon Rectum. 2013 Apr;56(4):416-21. doi: 10.1097/DCR.0b013e318274d9c6.

PMID:
23478608
3.

Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.

Govindarajan A, Reidy D, Weiser MR, Paty PB, Temple LK, Guillem JG, Saltz LB, Wong WD, Nash GM.

Ann Surg Oncol. 2011 Dec;18(13):3666-72. doi: 10.1245/s10434-011-1788-y. Epub 2011 May 18.

PMID:
21590450
4.

Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.

Pacelli F, Sanchez AM, Covino M, Tortorelli AP, Bossola M, Valentini V, Gambacorta MA, Doglietto GB.

Am Surg. 2013 Feb;79(2):151-61.

PMID:
23336654
5.

[Rectal cancer: current status of multimodal therapy--when and how?].

Gaedcke J, Liersch T, Hess C, Becker H, Rödel C, Ghadimi BM.

Zentralbl Chir. 2011 Aug;136(4):334-42. doi: 10.1055/s-0031-1271581. Epub 2011 Aug 23. Review. German.

PMID:
21863511
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.

Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, Boz G, Innocente R, Perin T, Cossaro M, Polesel J, De Marchi F.

Ann Surg Oncol. 2011 Dec;18(13):3686-93. doi: 10.1245/s10434-011-1822-0. Epub 2011 Jun 21.

8.

Multidisciplinary treatment of resectable rectal cancer.

Ayala DN, Russo SM, Blackstock AW.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):383-94. doi: 10.1586/egh.09.33. Review.

PMID:
19673625
9.

Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?

Hughes R, Harrison M, Glynne-Jones R.

Acta Oncol. 2010 Apr;49(3):378-81. doi: 10.3109/02841860903483692.

PMID:
20151936
10.

Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).

Dewdney A, Cunningham D, Tabernero J, Capdevila J, Glimelius B, Cervantes A, Tait D, Brown G, Wotherspoon A, Gonzalez de Castro D, Chua YJ, Wong R, Barbachano Y, Oates J, Chau I.

J Clin Oncol. 2012 May 10;30(14):1620-7. doi: 10.1200/JCO.2011.39.6036. Epub 2012 Apr 2.

11.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

12.

Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.

Gollins S.

Colorectal Dis. 2010 Aug;12 Suppl 2:2-24. doi: 10.1111/j.1463-1318.2010.02320.x. Review.

PMID:
20618363
13.

Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer.

Sclafani F, Cunningham D.

Future Oncol. 2014 Nov;10(14):2243-57. doi: 10.2217/fon.14.127. Review.

14.

Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?

Lombardi R, Cuicchi D, Pinto C, Di Fabio F, Iacopino B, Neri S, Tardio ML, Ceccarelli C, Lecce F, Ugolini G, Pini S, Di Tullio P, Taffurelli M, Minni F, Martoni A, Cola B.

Ann Surg Oncol. 2010 Mar;17(3):838-45. doi: 10.1245/s10434-009-0796-7. Epub 2009 Dec 12.

PMID:
20012700
15.

[Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].

Rougier P, Mitry E, Clavéro-Fabri MC, Penna C, Nordlinger B.

Ann Chir. 1999;53(10):1011-8. Review. French.

PMID:
10670150
16.

Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer.

McCarthy K, Pearson K, Fulton R, Hewitt J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008368. doi: 10.1002/14651858.CD008368.pub2. Review.

PMID:
23235660
17.

The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of rectal cancer.

Glynne-Jones R, Mathur P, Elton C, Train ML.

Best Pract Res Clin Gastroenterol. 2007;21(6):1049-70. Review.

PMID:
18070703
18.

[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].

Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I.

Orv Hetil. 2006 Oct 22;147(42):2011-20. Review. Hungarian.

PMID:
17165600
19.

[Adjuvant and neoadjuvant therapy of rectal carcinoma. The current status].

Rödel C, Hohenberger W, Sauer R.

Strahlenther Onkol. 1998 Oct;174(10):497-504. Review. German.

PMID:
9810316
Items per page

Supplemental Content

Write to the Help Desk